These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 31351660)

  • 1. The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX).
    Althof S; Osterloh IH; Muirhead GJ; George K; Girard N;
    J Sex Med; 2019 Aug; 16(8):1188-1198. PubMed ID: 31351660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).
    McMahon C; Althof S; Rosen R; Giuliano F; Miner M; Osterloh IH; Muirhead GJ; Harty B;
    J Sex Med; 2019 Aug; 16(8):1178-1187. PubMed ID: 31351659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist-Cligosiban-in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy Subjects.
    Osterloh IH; Muirhead GJ; Sultana S; Whaley S; van den Berg F; Atiee G
    J Sex Med; 2018 Nov; 15(11):1547-1557. PubMed ID: 30341006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose study.
    Shinghal R; Barnes A; Mahar KM; Stier B; Giancaterino L; Condreay LD; Black L; McCallum SW
    J Sex Med; 2013 Oct; 10(10):2506-17. PubMed ID: 23937679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, Safety, and Tolerability of Multiple Doses of the Novel Oxytocin Receptor Antagonist Cligosiban in Development for Premature Ejaculation: Two Randomized Clinical Trials in Healthy Subjects.
    Muirhead GJ; Osterloh IH; Whaley S; van den Berg F
    J Sex Med; 2019 Feb; 16(2):213-222. PubMed ID: 30612858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cligosiban, A Novel Brain-Penetrant, Selective Oxytocin Receptor Antagonist, Inhibits Ejaculatory Physiology in Rodents.
    Wayman C; Russell R; Tang K; Weibly L; Gaboardi S; Fisher L; Allers K; Jackson M; Hawcock T; Robinson N; Wilson L; Gupta J; Casey J; Gibson KR
    J Sex Med; 2018 Dec; 15(12):1698-1706. PubMed ID: 30527053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
    Dinsmore WW; Wyllie MG
    BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study.
    Carson C; Wyllie M
    J Sex Med; 2010 Sep; 7(9):3179-89. PubMed ID: 20584124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective and Subjective Measures of Premature Ejaculation: How Closely Do They Correspond and How Well Are the Subjective Measures Recalled?
    Althof S; Rosen R; Harty B; Osterloh IH; Muirhead GJ; McMahon C
    J Sex Med; 2020 Apr; 17(4):634-644. PubMed ID: 32089486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Double Blind, Placebo Controlled, Randomized Trial to Evaluate the Efficacy and Tolerability of On-Demand Oral Pregablin (150 mg and 75 mg) in Treatment of Premature Ejaculation.
    El Najjar MR; El Hariri M; Ramadan A; Hefny Hashem AA
    J Sex Med; 2020 Mar; 17(3):442-446. PubMed ID: 31982359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel on-demand therapy for lifelong premature ejaculation using a miniature transperineal electrical stimulator-the vPatch: an as-treated analysis.
    Shechter A; Mondaini N; Serefoglu EC; Gollan T; Deutsch F; Appel B; Gruenwald I
    J Sex Med; 2023 Jan; 20(1):22-29. PubMed ID: 36897239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
    McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
    J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
    Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
    BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin re-uptake inhibitors for premature ejaculation in adult men.
    Sathianathen NJ; Hwang EC; Mian R; Bodie JA; Soubra A; Lyon JA; Sultan S; Dahm P
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012799. PubMed ID: 33745183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation.
    Aversa A; Pili M; Francomano D; Bruzziches R; Spera E; La Pera G; Spera G
    Int J Impot Res; 2009; 21(4):221-7. PubMed ID: 19474796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study.
    Lee WK; Lee SH; Cho ST; Lee YS; Oh CY; Yoo C; Cho JS; Lee SK; Yang DY
    J Sex Med; 2013 Nov; 10(11):2832-41. PubMed ID: 23937271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED Study.
    Tuken M; Culha MG; Serefoglu EC
    Int J Impot Res; 2019 Mar; 31(2):92-96. PubMed ID: 30705437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
    McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J;
    J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study.
    Mattos RM; Marmo Lucon A; Srougi M
    Urol Int; 2008; 80(2):162-5. PubMed ID: 18362486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes.
    Bar-Or D; Salottolo KM; Orlando A; Winkler JV;
    Eur Urol; 2012 Apr; 61(4):736-43. PubMed ID: 21889833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.